The Enterprise Value as of December 2024 (TTM) for Chimerix, Inc. (CMRX) is 248.61M

According to Chimerix, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 248.61M. This represents a change of 281.62% compared to the average of 65.15M of the last 4 quarters.

Chimerix, Inc. (CMRX) Historical Enterprise Value (quarterly & annually)

How has CMRX Enterprise Value performed in the past?

The mean historical Enterprise Value of Chimerix, Inc. over the last ten years is 307.91M. The current 248.61M Enterprise Value has changed 7.97% with respect to the historical average. Over the past ten years (40 quarters), CMRX's Enterprise Value was at its highest in in the June 2015 quarter at 1.82B. The Enterprise Value was at its lowest in in the September 2022 quarter at -102907666.16.

Chimerix, Inc. (CMRX) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Chimerix, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Chimerix, Inc. (CMRX) Average Enterprise Value

How has CMRX Enterprise Value performed in the past?

The current Enterprise Value of Chimerix, Inc. (CMRX) is greater than its 3-year, greater than its 5-year, and less than than its 10-year historical averages

Chimerix, Inc. (CMRX) Enterprise Value vs. Peers

How is CMRX’s Enterprise Value compared to its peers?

Chimerix, Inc.’s Enterprise Value is greater than Assembly Biosciences, Inc. (67.83M), greater than Spero Therapeutics, Inc. (-21358605.00), greater than Achilles Therapeutics plc (-42104641.00), greater than Instil Bio, Inc. (220.42M), greater than Neoleukin Therapeutics, Inc. (-6333315.00), greater than CytomX Therapeutics, Inc. (55.32M), greater than NextCure, Inc. (4.04M), less than Day One Biopharmaceuticals, Inc. (859.59M), greater than X4 Pharmaceuticals, Inc. (79.21M), less than Mereo BioPharma Group plc (445.16M), greater than Terns Pharmaceuticals, Inc. (234.86M),

Build a custom stock screener for Chimerix, Inc. (CMRX) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Chimerix, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Chimerix, Inc. (CMRX) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Chimerix, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.